Literature DB >> 6984667

Neutrophil product with lymphocyte activating factor activity.

P J Harris.   

Abstract

Lymphocyte activating factor (LAF) is a monocyte derived product which has the ability to enhance the proliferative response of murine thymocytes to the T cell mitogen concanavalin A (Con A). In this report, we have demonstrated that supernatants from normal human polymorphonuclear cells (PMNs) and from granules obtained from PMNs exhibit activity identical to LAF when tested against mouse thymocytes. Our results suggest that PMNs may release factors essential for T cell activation and thus, like monocytes, may serve as important accessory cells in the development of T cell-dependent immunity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6984667      PMCID: PMC1536821     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  Interaction between lymphocytes and inflammatory exudate cells. II. A proteolytic enzyme released by PMN as a possible mediator for enhancement of thymocyte response.

Authors:  S Nakamura; M Yoshinaga; H Hayashi
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

2.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

3.  The adherence of leucocytes and platelets induced by fixed IgG antibody or complement.

Authors:  P M Henson
Journal:  Immunology       Date:  1969-01       Impact factor: 7.397

4.  Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Preparation and characterization of lymphocyte-activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells.

Authors:  L B Lachman; J O Moore; R S Metzgar
Journal:  Cell Immunol       Date:  1978-11       Impact factor: 4.868

Review 6.  The antigenic characteristics of hematopoietic stem cells.

Authors:  J H Fitchen; K A Foon; M J Cline
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

Review 7.  Chronic myelogenous leukemia--new concepts (first of two parts).

Authors:  H P Koeffler; D W Golde
Journal:  N Engl J Med       Date:  1981-05-14       Impact factor: 91.245

8.  Separation and characterization of human neutrophil granules.

Authors:  B C West; A S Rosenthal; N A Gelb; H R Kimball
Journal:  Am J Pathol       Date:  1974-10       Impact factor: 4.307

9.  Demonstration and characterization of two distinct human leukocytic pyrogens.

Authors:  C A Dinarello; N P Goldin; S M Wolff
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

  9 in total
  3 in total

1.  Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease.

Authors:  J T Whicher; A M Gilbert; C Westacott; C Hutton; P A Dieppe
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

2.  Effects of supernatants and lysates of polymorphonuclear leucocytes: macrophage stimulatory factors.

Authors:  J Bird; Y J Sheng; J P Giroud
Journal:  Br J Exp Pathol       Date:  1984-04

3.  Antitumor effect induced by a hot water extract of Chlorella vulgaris (CE): resistance to Meth-A tumor growth mediated by CE-induced polymorphonuclear leukocytes.

Authors:  F Konishi; K Tanaka; K Himeno; K Taniguchi; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.